XML 267 R96.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-based payments - 2022 grants to CEO and CFO (Details)
€ / shares in Units, $ / shares in Units, € in Thousands
1 Months Ended 12 Months Ended
Jun. 26, 2023
EUR (€)
Jun. 12, 2023
USD ($)
May 27, 2022
EquityInstruments
€ / shares
Feb. 01, 2022
USD ($)
EquityInstruments
Feb. 01, 2022
€ / shares
Jan. 31, 2022
USD ($)
Jan. 31, 2022
EUR (€)
May 31, 2022
shares
Dec. 31, 2023
USD ($)
shares
tranche
$ / shares
Dec. 31, 2023
EUR (€)
shares
tranche
installment
Dec. 31, 2022
EUR (€)
shares
Options
Dec. 31, 2021
EUR (€)
Options
Dec. 31, 2022
$ / shares
Share-based payments                          
Share-based payments | €                   € 2,158 € (1,461) € 5,471  
Value of other equity instruments granted under share based payment arrangement           $ 3,200,000 € 2,800            
Chief Executive Officer                          
Share-based payments                          
Cash Bonus in Share-Based Payment Arrangement                 $ 750,000        
CFO                          
Share-based payments                          
Cash Bonus in Share-Based Payment Arrangement                 300,000        
Chief Executive Officer and Chief Financial Officer [Member]                          
Share-based payments                          
Incremental fair value   $ 0             20,000        
If the Capital Raise is at least EUR 10,000k | Chief Executive Officer                          
Share-based payments                          
Cash Bonus in Share-Based Payment Arrangement                 375,000        
Capital Raise | €                   10,000      
If the Capital Raise is at least EUR 10,000k | CFO                          
Share-based payments                          
Cash Bonus in Share-Based Payment Arrangement                 150,000        
If the capital raise exceeds EUR 10,000k | Chief Executive Officer                          
Share-based payments                          
Cash Bonus in Share-Based Payment Arrangement                 $ 300,000        
Capital Raise | €                   € 10,000      
Capital Raise | Pharmaceutical Investment Company                          
Share-based payments                          
Share-based payments | € € 997                        
RSUs | Chief Executive Officer                          
Share-based payments                          
Contractual life       10 years                  
Exercise price | € / shares         € 0                
Vesting period                 3 years 3 years      
Exercised during the year | $ / shares                 $ 7        
RSUs | CFO                          
Share-based payments                          
Contractual life     10 years                    
Exercise price | € / shares     € 0                    
Percentage cash bonus in share-based payment arrangement                 1.50% 1.50%      
Performance Based RSUs | CFO                          
Share-based payments                          
RSUs granted | EquityInstruments     58,132                    
Time Based RSUs | CFO                          
Share-based payments                          
RSUs granted | EquityInstruments     55,556                    
Restricted Stock Units and Maximum Additional Restricted Stock Unit [Member] | Chief Executive Officer and Chief Financial Officer [Member] | Minimum                          
Share-based payments                          
Vesting percentage                 50.00% 50.00%      
Restricted Stock Units and Maximum Additional Restricted Stock Unit [Member] | Chief Executive Officer and Chief Financial Officer [Member] | Maximum                          
Share-based payments                          
Vesting percentage                 100.00% 100.00%      
SGAs                          
Share-based payments                          
RSUs granted | shares                 908,192 908,192      
Number                          
Exercised during the year | shares                 0 0      
Subject to time-vesting and performance vesting | Chief Executive Officer                          
Share-based payments                          
Number of Installments | installment                   4      
Subject to time-vesting and performance vesting | RSUs | Chief Executive Officer                          
Share-based payments                          
RSUs granted | EquityInstruments       174,394                  
Share based awards subject to time-vesting [Member] | RSUs | Chief Executive Officer                          
Share-based payments                          
RSUs granted       166,667             1,052,227    
Share based awards subject to time-vesting [Member] | RSUs | CFO                          
Share-based payments                          
RSUs granted | shares               443,628          
Annual RSUs | RSUs | Chief Executive Officer                          
Share-based payments                          
RSUs granted | EquityInstruments       44,444                  
Annual RSUs | Other RSUs granted to CEO | Chief Executive Officer                          
Share-based payments                          
Value of other equity instruments granted under share based payment arrangement       $ 200,000                  
2019 Plan | RSUs                          
Share-based payments                          
RSUs granted | Options                       167,326  
WAEP                          
Vested as of December 31 | $ / shares                         $ 1.0
2019 Plan | RSUs | Minimum                          
Share-based payments                          
Number of tranches | tranche                 3 3      
2019 Plan | RSUs | Maximum                          
Share-based payments                          
Number of tranches | tranche                 4 4      
2019 Plan | SGAs                          
Share-based payments                          
RSUs granted                 908,192 908,192 425,093    
2019 Plan | SGAs | Minimum                          
Share-based payments                          
Vesting period                 3 years 3 years      
Number of tranches | tranche                 3 3      
2019 Plan | SGAs | Maximum                          
Share-based payments                          
Vesting period                 4 years 4 years      
Number of tranches | tranche                 4 4